Acquisition aims to provide broader access to comprehensive testing and laboratory services for patients and physicians in North Mississippi BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory… Read More
Building on the last approval of Jemperli offering PFS benefit in dMMR/MSI-HC endometrial cancer, the expanded indication now offers survival benefit across the overall study population (dMMR/MSI-H and MMRp/MSS tumours) Approval based… Read More
Labcorp Diagnostic AssistantTM recognized for improving patient care BURLINGTON, NC — Labcorp (NYSE: LH), a global leader of innovative and comprehensive diagnostic laboratory services, announced it has received a Modern Healthcare 2025 Innovators… Read More
SPINEstat™, a novel, first-in-class diagnostic blood test for axial spondyloarthritis (axSpA), has been approved by Health Canada. This approval marks an important milestone in addressing a significant global unmet need… Read More
The Province is accelerating the future of patient care and advancing testing for cancer, heart disease, transplants and infections with eight new genomics research projects, in partnership with Genome BC… Read More
